Full-size Left-side Hidden
REFERENCES

1. World Health Organization : The World Health Report 1998. Life in the 21st Century: A Vision for All,  Geneva, WHO, 1998.

2. Löch FD: Massive development of amebas in the large intestine. Translated and reprinted in. Am J Trop Med Hyg  1875; 24:383-392.

3. Osler W: On the Amoeba coli in dysentery and in dysenteric liver abscess. Johns Hopkins Hosp Bull  1890; 1:53-54.

4. Councilman WT, Lafleur HA: Amoebic dysentery. Johns Hopkins Hosp Rep  1891; 2:395-548.

5. Schaudinn F: Untersuchungen über die Fortpflanzung einiger Rhizopoden (Vorläufige Mittheilung). Arb Kaiserlichen Gesundheitsamte  1903; 19:547-576.

6. Walker EL, Sellards AW: Experimental entamoebic dysentery. Philippine J Sci B Trop Med  1913; 8:253-330.

7. Brumpt E: Etude sommaire de l' ‘Entamoeba dispar’ n. sp. Amibe à kystes quandrinuclées, parasite de l'homme. Bull Acad Med (Paris)  1925; 94:943-952.

8. Sargeaunt PG, Williams JE, Grene JD: The differentiation of invasive and non-invasive Entamoeba histolytica by isoenzyme electrophoresis. Trans R Soc Trop Med Hyg  1978; 72:519-521.

9. Sargeaunt PG, Williams JE: Electrophoretic isoenzyme patterns of the pathogenic and non-pathogenic intestinal amoebae of man. Trans R Soc Trop Med Hyg  1979; 73:225-227.

10. Diamond LS, Clark CG: A redescription of Entamoeba histolytica Schaudinn, 1903 (Amended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. J Eukaryot Microbiol  1993; 40:340-344.

11. WHO/PAHO/UNESCO : A consultation with experts on amoebiasis. Mexico City, Mexico 28-29 January, 1997. Epidemiol Bull  1997; 18:13-14.

12. WHO : Amoebiasis. Wkly Epidemiol Rec  1997; 72:97-99.

13. Cavalier-Smith T: Kingdom protozoa and its 18 phyla. Microbiol Rev  1993; 57:953-994.

14. Silberman JD, Clark CG, Diamond LS, et al: Phylogeny of the genera Entamoeba and Endolimax as deduced from small-subunit ribosomal RNA sequences. Mol Biol Evol  1999; 16:1740-1751.

15. Mai Z, Ghosh S, Frisardi M, et al: Hsp60 is targeted to a cryptic mitochondrion-derived organelle (‘crypton’) in the microaerophilic protozoan parasite Entamoeba histolytica. Mol Cell Biol  1999; 19:2198-2205.

16. Tovar J, Fischer A, Clark CG: The mitosome, a novel organelle related to mitochondria in the amitochondrial parasite Entamoeba histolytica. Mol Microbiol  1999; 32:1013-1021.

17. Azam A, Paul J, Sehgal D, et al: Identification of novel genes from Entamoeba histolytica by expressed sequence tag analysis. Gene  1996; 181:113-116.

18. Cavalier-Smith T: A revised six-kingdom system of life. Biol Rev Camb Philos Soc  1998; 73:203-266.

19. Ghosh S, Field J, Rogers R, et al: The Entamoeba histolytica mitochondrion-derived organelle (crypton) contains double-stranded DNA and appears to be bound by a double membrane. Infect Immun  2000; 68:4319-4322.

20. Diamond LS: Techniques of axenic cultivation of Entamoeba histolytica Schaudinn, 1903 and E. histolytica-like amebae. J Parasitol  1968; 54:1047-1056.

21. Reeves RE: Metabolism of Entamoeba histolytica Schaudinn, 1903. Adv Parasitol  1984; 23:105-142.

22. Rosenthal B, Mai Z, Caplivski D, et al: Evidence for the bacterial origin of genes encoding fermentation enzymes of the amitochondriate protozoan parasite Entamoeba histolytica. J Bacteriol  1997; 179:3736-3745.

23. Rodriguez MA, Garcia-Perez RM, Mendoza L, et al: The pyruvate: ferredoxin oxidoreductase enzyme is located in the plasma membrane and in a cytoplasmic structure in Entamoeba. Microb Pathog  1998; 25:1-10.

24. Ali IK, Zaki M, Clark CG: Use of PCR amplification of tRNA gene-linked short tandem repeats for genotyping Entamoeba histolytica. J Clin Microbiol  2005; 43:842-847.

25. Walsh JA: Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis  1986; 8:228-238.

26. Gathiram V, Jackson TF: A longitudinal study of asymptomatic carriers of pathogenic zymodemes of Entamoeba histolytica. S Afr Med J  1987; 72:669-672.

27. Fotedar R, Stark D, Beebe N, et al: PCR detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in stool samples from Sydney, Australia. J Clin Microbiol  2007; 45:1035-1037.

28. Ramos F, Moran P, Gonzalez E, et al: Entamoeba histolytica and Entamoeba dispar: prevalence of infection in a rural Mexican community. Exp Parasitol  2005; 110:327-330.

29. Adams SA, Robson SC, Gathiram V, et al: Immunological similarity between the 170 kD amoebic adherence glycoprotein and human beta 2 integrins. Lancet  1993; 341:17-19.

30. Huston CD, Houpt ER, Mann BJ, et al: Caspase 3-dependent killing of host cells by the parasite Entamoeba histolytica. Cell Microbiol  2000; 2:617-625.

31. Leippe M, Bruhn H, Hecht O, et al: Ancient weapons: the three-dimensional structure of amoebapore A. Trends Parasitol  2005; 21:5-7.

32. Leon G, Fiori C, Das P, et al: Electron probe analysis and biochemical characterization of electron-dense granules secreted by Entamoeba histolytica. Mol Biochem Parasitol  1997; 85:233-242.

33. Que X, Reed SL: Cysteine proteinases and the pathogenesis of amebiasis. Clin Microbiol Rev  2000; 13:196-206.

34. Yu Y, Chadee K: Entamoeba histolytica stimulates interleukin 8 from human colonic epithelial cells without parasite-enterocyte contact. Gastroenterology  1997; 112:1536-1547.

35. Seydel KB, Li E, Swanson PE, et al: Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis. Infect Immun  1997; 65:1631-1639.

36. Reed SL, Ember JA, Herdman DS, et al: The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a. J Immunol  1995; 155:266-274.

37. Haque R, Mondal D, Duggal P, et al: Entamoeba histolytica infection in children and protection from subsequent amoebiasis. Infect Immun  2006; 74:904-909.

38. De Leon A: Pronóstico tardìo en el absceso hepático amibiano. Arch Invest Med  1970; 1:205-206.

39. Moran P, Ramos F, Ramiro M, et al: Infection by HIV-1 is not a risk for amebiasis. Am J Trop Med Hyg  2005; 73:296-300.

40. Kelsall BL, Ravdin JI: Degradation of human IgA by Entamoeba histolytica. J Infect Dis  1993; 168:1319-1322.

41. Tran VQ, Herdman DS, Torian BE, et al: The neutral cysteine proteinase of Entamoeba histolytica degrades IgG and prevents its binding. J Infect Dis  1998; 177:508-511.

42. Carrada-Bravo T: Invasive amebiasis as a public health problem. Biol Med Hosp Infant Mex  1989; 46:139-148.

43. Haque R, Neville LM, Hahn P, et al: Rapid diagnosis of Entamoeba infection by using Entamoeba and Entamoeba histolytica stool antigen detection kits. J Clin Microbiol  1995; 33:2558-2561.

44. Freeman O, Akamaguna A, Jarikre LN: Amoebic liver abscess: the effect of aspiration on the resolution or healing time. Ann Trop Med Parasitol  1990; 84:281-287.

45. Weinke T, Friedrich-Janicke B, Hopp P, et al: Prevalence and clinical importance of Entamoeba histolytica in two high-risk groups: travelers returning from the tropics and male homosexuals. J Infect Dis  1990; 161:1029-1031.

46. Vohra H, Bhatti HS, Ganguly NK, et al: Virulence of pathogenic and non-pathogenic zymodemes of Entamoeba histolytica (Indian strains) in guinea-pigs. Trans R Soc Trop Med Hyg  1989; 83:648-650.

47. Bruchhaus I, Jacobs T, Leippe M, et al: Entamoeba histolytica and Entamoeba dispar: differences in numbers and expression of cysteine proteinase genes. Mol Microbiol  1996; 22:255-263.

48. Espinosa-Cantellano M, Gonzales-Robles A, Chavez B, et al: Entamoeba dispar: ultrastructure, surface properties and cytopathic effect. J Eukaryot Microbiol  1998; 45:265-272.

49. Walderich B, Weber A, Knobloch J: Sensitivity of Entamoeba histolytica and Entamoeba dispar patient isolates to human complement. Parasite Immunol  1997; 19:265-271.

50. Sargeaunt PG, Patrick S, O'Keeffe D: Human infections of Entamoeba chattoni masquerade as Entamoeba histolytica. Trans R Soc Trop Med Hyg  1992; 86:633-634.

51. Stark DJ, Beebe N, Marriott D, et al: Dientamoebiasis: clinical importance and recent advances. Trends Parasitol  2006; 22:92-96.

52. Johnson JA, Clark CG: Cryptic genetic diversity in Dientamoeba fragilis. J Clin Microbiol  2000; 38:4653-4654.

53. Farthing MJG: Giardiasis as a disease.   In: Reynoldson JA, Thompson RCA, Lymbery AJ, ed. Giardia: From Molecules to Disease and Beyond,  London: CAB International; 1993:15-37.

54. Kabnick KS, Peattie DA: Giardia: a missing link between prokaryotes and eukaryotes. Am Sci  1991; 79:34-43.

55. Cox FEG: Classification and introduction to the parasitic protozoa.   In: Cox FEG, Wakelin D, Gillespie SH, Despommier DD, ed. Topley, Wilson's Parasitology,  10th edn.. London: Edward Arnold; 2007:186-199.

56. Bauer B, Engelbrecht S, Bakker-Grunwald T, et al: Functional identification of alpha 1-giardin as an annexin of Giardia lamblia. FEMS Microbiol Lett  1999; 173:147-153.

57. Hetsko ML, McCaffery JM, Svard SG, et al: Cellular and transcriptional changes during excystation of Giardia lamblia in vitro. Exp Parasitol  1998; 88:172-183.

58. Farthing MJG, Keusch GT, Carey MC: Effects of bile and bile salts on growth and membrane lipid uptake by Giardia lamblia: possible implication for pathogenesis of intestinal disease. J Clin Invest  1985; 76:1727-1732.

59. Knodler LA, Svard SG, Silberman JD, et al: Developmental gene regulation in Giardia lamblia: first evidence for an encystation-specific promoter and differential 5′ mRNA processing. Mol Microbiol  1999; 34:327-340.

60. Adam RD: The Giardia lamblia genome. Int J Parasitol  2000; 30:475-484.

61. Sullivan PB, Marsh MN, Phillips MB, et al: Prevalence and treatment of giardiasis in chronic diarrhoea and malnutrition. Arch Dis Child  1991; 66:304-306.

62. Jokipii L, Jokipii AM: Giardiasis in travelers: a prospective study. J Infect Dis  1974; 30:295-299.

63. Karanis P, Kourenti C, Smith H: Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt. J Water Health  2007; 5:1-38.

64. Furness BW, Beach MJ, Roberts JM: Giardiasis surveillance - United States, 1992-1997. Morbid Mortal Weekly  2000; 49:1-13.

65. Katelaris PH, Farthing MJG: Diarrhoea and malabsorption in giardiasis: a multifactorial process. Gut  1992; 33:295-297.

66. Buret AG: Mechanisms of epithelial dysfunction in giardiasis. Gut  2007; 56:316-317.

67. Troeger H, Epple H-J, Schneider T, et al: Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum. Gut  2007; 56:328-335.

68. Teoh DA, Kamieniecki D, Pang G, et al: Giardia lamblia rearranges F-actin and alpha-actinin in human colonic and duodenal monolayers and reduces transepithelial electrical resistance. J Parasitol  2000; 86:800-806.

69. Scott KG, Logan MR, Klammer GM, et al: Jejunal brush border microvillous alterations in Giardia muris-infected mice: role of T lymphocytes and interleukin-6. Infect Immun  2000; 68:3412-3418.

70. Das S, Schteingart CD, Hofmann AF, et al: Giardia lamblia: evidence for carrier-mediated uptake and release of conjugated bile acids. Exp Parasitol  1997; 87:133-141.

71. Seow F, Katelaris PH, Ngu M: The effect of Giardia lamblia trophozoites on trypsin, chymotrypsin and amylase in vitro. Parasitology  1993; 106:233-238.

72. Faubert G: Immune response to Giardia duodenalis. Clin Microbiol Rev  2000; 13:35-54.

73. Farthing MJG, Chong S, Walker-Smith JA: Acute allergic phenomena in giardiasis. Lancet  1984; ii:1428.

74. Singer SM, Nash TE: T-cell-dependent control of acute Giardia lamblia infections in mice. Infect Immun  2000; 68:170-175.

75. Char S, Cevallos AM, Yamson P, et al: Impaired IgA response to Giardia heat shock antigen in children with persistent diarrhoea and giardiasis. Gut  1992; 34:38-40.

76. Sullivan PB, Lunn PG, Northrop-Clewes CA, et al: Parasitic infection of the gut and protein-losing enteropathy. J Pediatr Gastroenterol Nutr  1992; 15:404-407.

77. Goka AKJ, Rolston DDK, Mathan VI, et al: The relative merits of faecal and duodenal juice microscopy in the diagnosis of giardiasis. Trans R Soc Trop Med Hyg  1990; 84:66-67.

78. Oster N, Gehrig-Feistel H, Jung H, et al: Evaluation of the immunochromatographic CORIS Giardia strip test for rapid diagnosis of Giardia lamblia. Eur  2006; 25:112-115.

79. Weitzel T, Dittrich S, Mohl I, et al: Evaluation of seven commercial antigen detection tests for Giardia and Cryptosporidium in stool samples. Clin Microbiol Infect  2006; 12:656-659.

80. Amar CF, East CL, Gray J, et al: Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples. J Clin Microbiol Infect Dis  2007; 26:311-323.

81. Meloni BP, Thompson RCA, Reynoldson JA, et al: Albendazole: a more effective antiGiardial agent in vitro than metronidazole or tinidazole. Trans R Soc Trop Med Hyg  1990; 84:375-379.

82. Crouch AA, Seow WK, Whitman LM, et al: Sensitivity in vitro of Giardia intestinalis to dyadic combinations of azithromycin, doxycycline, mefloquine, tinidazole and furazolidone. Trans R Soc Trop Med Hyg  1990; 84:246-248.

83. Rossignol JF, Ayoub A, Ayers MS: Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis  2001; 184:381-384.

84. Arean VM, Koppisch E: Balantidiasis: a review and report of cases. Am J Pathol  1956; 32:1089-1115.

85. Walzer PD, Judson FN, Murphy KB, et al: Balantidiasis outbreak in Truk. Am J Trop Med Hyg  1973; 22:33-41.

86. Tyzzer EE: A sporozoan found in the peptic glands of the common mouse. Proc Soc Exp Biol Med  1907; 5:12-13.

87. Xiao L, Fayer R, Ryan U, et al: Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev  2004; 17:72-97.

88. Smith HV, Rose JB: Waterborne cryptosporidiosis. Parasitol Today  1990; 6:8-12.

89. Casemore DP: Epidemiological aspects of human cryptosporidiosis. Epidemiol Infect  1990; 104:1-28.

90. Zu SX, Zhu SY, Li JF: Human cryptosporidiosis in China. Trans R Soc Trop Med Hyg  1992; 86:639-640.

91. Molbak K, Hojlyng N, Gottschau A, et al: Cryptosporidiosis in infancy and childhood mortality in Guinea-Bissau, West Africa. BMJ  1993; 307:417-420.

92. Ravn P, Lungren JD, Kjaeldgaard P, et al: Nosocomial outbreak of cryptosporidiosis in AIDS patients. BMJ  1991; 302:277-280.

93. Blanshard C, Jackson AM, Shanson DC, et al: Cryptosporidiosis in HIV seropositive patients. Q J Med  1992; 85:813-823.

94. Phillips AD, Thomas AG, Walker-Smith JA: Cryptosporidium, chronic diarrhoea and the proximal small intestinal mucosa. Gut  1992; 33:1057-1061.

95. Kelly P, Makumbi FA, Carnaby S, et al: Variable distribution of Cryptosporidium parvum in small and large intestine in AIDS revealed by polymerase chain reaction. Eur J Gastro Hepatol  1998; 10:855-858.

96. Kelly P, Thillainayagam AV, Smithson J, et al: Jejunal water and electrolyte transport in human cryptosporidiosis. Dig Dis Sci  1996; 41:2095-2099.

97. O'Hara SP, Small AJ, Nelson JB, et al: The HIV-1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism. Infect Immun  2007; 75:684-696.

98. MacDonald V, Kelly P: Intestinal coccidia: cryptosporidiosis, isosporiasis, cyclosporiasis.   In: Cox FEG, Wakelin D, Gillespie SH, Despommier DD, ed. Topley, Wilson's Parasitology,  10th edn.. London: Edward Arnold; 2007:399-421.

99. Jacyna MR, Parkin J, Goldin R, et al: Protracted enteric cryptosporidial infection in selective immunoglobulin A and saccharomyces opsonin deficiencies. Gut  1990; 31:714-716.

100. Kelly P, Jack D, Naeem A, et al: Mannose binding lectin is a contributor to mucosal defence against Cryptosporidium parvum in AIDS patients. Gastroenterology  2000; 119:1236-1242.

101. Connolly GM, Dryden MS, Shanson DC, et al: Cryptosporidial diarrhoea in AIDS and its treatment. Gut  1988; 29:593-597.

102. McGowan I, Hawkins A, Weller I: The natural history of cryptosporidial diarrhoea in HIV infected patients. AIDS  1993; 7:349-354.

103. Colebunders R, Francis H, Mann JM, et al: Persistent diarrhea, strongly associated with HIV infection in Kinshasa, Zaire. Am J Gastroenterol  1987; 82:859-864.

104. Teixidor HS, Godwin TA, Ramirez EA: Cryptosporidiosis of the biliary tract in AIDS. Radiology  1991; 180:51-56.

105. Forbes A, Blanshard C, Gazzard B: Natural history of AIDS related sclerosing cholangitis: a study of 20 cases. Gut  1993; 34:116-121.

106. Molbak K, Andersen M, Aaby P, et al: Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, West Africa. Am J Clin Nutr  1997; 65:149-152.

107. Amadi BC, Kelly P, Mwiya M, et al: Intestinal and systemic infection, HIV and mortality in Zambian children with persistent diarrhoea and malnutrition. J Pediatr Gastroenterol Nutr  2001; 32:550-554.

108. Weber R, Bryan RT, Bishop HS, et al: Threshold of detection of Cryptosporidium oocysts in human stool specimens: evidence for low sensitivity of current diagnostic methods. J Clin Microbiol  1991; 29:1323-1327.

109. Amadi BC, Mwiya M, Musuku J, et al: Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet  2002; 360:1375-1380.

110.  Abubakar I, Aliyu SH, Arumugam C, et al. Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Database of Systematic Reviews 2007, Issue 1. Art No. CD004932. DOI:10.1002/14651858.CD004932.pub2.

111. Casemore DP, Blewett DA, Wright SE: Cleaning and disinfection of equipment for gastrointestinal flexible endoscopy: interim recommendations of a working party of the British Society of Gastroenterology. Gut  1990; 31:1156-1157.(letter).

112. Stürchler D: Parasitic diseases of the small intestinal tract. Bailli è res Clin Gastroenterol  1987; 1:397-424.

113. Brandborg LL, Goldberg SB, Breidenbach WC: Human coccidiosis - a possible cause of malabsorption. N Engl J Med  1970; 283:1306-1313.

114. Trier JS, Moxey PC, Schimmel EM, et al: Chronic intestinal coccidiosis in man: intestinal pathology and response to treatment. Gastroenterology  1974; 66:923-935.

115. De Hovitz JA, Pape JW, Boncy M, et al: Clinical manifestations and therapy of Isospora belli infection in patients with AIDS. N Engl J Med  1986; 315:87-90.

116. Pape JW, Verdier RI, Johnson WD: Treatment and prophylaxis of Isospora belli infections in patients with AIDS. N Engl J Med  1989; 320:1044-1047.

117. Ortega YR, Sterling CR, Gilman RH, et al: Cyclospora species - a new protozoan pathogen of humans. N Engl J Med  1993; 328:1308-1312.

118. Sun T, Hardi CF, Asnis D, et al: Light and electron microscopic identification of Cyclospora species in the small intestine: evidence of the presence of asexual life cycle in human host. Am J Clin Pathol  1996; 105:215-220.

119. Relman DA, Schmidt TM, Gajadhar A, et al: Molecular phylogenetic analysis of Cyclospora, the human intestinal pathogen, suggests that it is closely related to Eimeria species. J Infect Dis  1996; 173:440-445.

120. Hoge CW, Shlim DR, Rajah R, et al: Epidemiology of diarrhoeal illness associated with coccidian-like organism among travellers and foreign residents in Nepal. Lancet  1993; 341:1175-1179.

121. Huang P, Weber JT, Sosin DM, et al: The first reported outbreak of diarrheal illness associated with Cyclospora in the United States. Ann Intern Med  1995; 123:409-414.

122. Herwaldt BI, Ackers M-L, Farrar J, et al: An outbreak in 1996 of cyclosporiasis associated with imported raspberries. N Engl J Med  1997; 336:1548-1556.

123. Bendall RP, Lucas S, Moody A, et al: Diarrhoea associated with cyanobacterium-like bodies: a new coccidian enteritis of man. Lancet  1993; 341:590-592.

124. Hoge CW, Shlim DR, Ghimire M, et al: Placebo-controlled trial of co-trimoxatole for Cyclospora infections among travellers and foreign residents in Nepal. Lancet  1995; 345:667-668.691-693.

125. Verdier R-I, Fitzgerald DW, Johnson Jr WD, et al: Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. Ann Intern Med  2000; 132:885-888.

126. Desportes-Livage I: Biology of microsporidia.   In: Petry F, ed. Cryptosporidiosis and Microsporidiosis. Contributions to Microbiology, Vol. 6. Basel: Karger; 2000:116-139.

127. Modigliani R, Bories C, le Charpentier Y, et al: Diarrhoea and malabsorption in AIDS: a study of four cases with special emphasis on opportunistic protozoan infections. Gut  1985; 26:179-187.

128. Cali A, Owen RL: Intracellular development of Enterocytozoon, a unique microsporidian found in the intestine of AIDS patients. J Protozool  1990; 37:145-155.

129. Orenstein JM, Tenner M, Kotler DP: Localization of infection by the microsporidian Enterocytozoon bieneusi in the gastrointestinal tract of AIDS patients with diarrhoea. AIDS  1992; 6:195-197.

130. Field AS, Hing MC, Millikan ST, et al: Microsporidia in the small intestine of HIV-infected patients. A new diagnostic technique and a new species. Med J Aust  1993; 158:390-394.

131. Pol S, Romana CA, Richard S, et al: Microsporidia infection in patients with HIV and unexplained cholangitis. N Engl J Med  1993; 328:95-99.

132. Weber R, Bryan RT, Owen RL, et al: Improved light microscopical detection of microsporidia spores in stool and duodenal aspirates. N Engl J Med  1992; 326:161-166.

133. Blanshard C, Ellis DS, Tovey DG, et al: Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS  1992; 6:311.

134. Molina JM, Tourneur M, Sarfati C, et al: Fumagillin treatment of intestinal microsporidiosis. New Engl J Med  2002; 346:1963-1969.

135. Molina JM, Oksenhendler E, Beauvais B, et al: Disseminated microsporidiosis due to Septata intestinalis in patients with AIDS: clinical features and response to albendazole therapy. J Infect Dis  1995; 171:245-249.